BMKDF (Biomark Diagnostics) Other Stockholders Equity : $0.57 Mil (As of Sep. 2024)

View and export this data going back to 2015. Start your Free Trial

What is Biomark Diagnostics Other Stockholders Equity?

Biomark Diagnostics's Other Stockholders Equity for the quarter that ended in Sep. 2024 was $0.57 Mil.

Biomark Diagnostics's quarterly Other Stockholders Equity increased from Mar. 2024 ($0.26 Mil) to Jun. 2024 ($0.53 Mil) and increased from Jun. 2024 ($0.53 Mil) to Sep. 2024 ($0.57 Mil).

Biomark Diagnostics's annual Other Stockholders Equity declined from Mar. 2022 ($0.52 Mil) to Mar. 2023 ($0.26 Mil) and declined from Mar. 2023 ($0.26 Mil) to Mar. 2024 ($0.26 Mil).

Biomark Diagnostics Other Stockholders Equity Historical Data

The historical data trend for Biomark Diagnostics's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biomark Diagnostics Other Stockholders Equity Chart

Biomark Diagnostics Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Other Stockholders Equity

Get a 7-Day Free Trial

-0.10

0.52

0.26

Biomark Diagnostics Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Other Stockholders Equity	Get a 7-Day Free Trial															0.68	-	0.26	0.53	0.57

Biomark Diagnostics Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity

Biomark Diagnostics Other Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Biomark Diagnostics's Other Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Biomark Diagnostics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Biomark Diagnostics Inc (OTCPK:BMKDF) » Definitions » Other Stockholders Equity

Comparable Companies

Traded in Other Exchanges

20B:Germany BUX:Canada

Address

130 - 3851 Shell Road, Richmond, BC, CAN, V6X 2W2

Website

https://www.biomarkdiagnostics.com

Biomark Diagnostics Inc is a Canada-based oncology-focused company. It is engaged in the development of the early-stage cancer diagnostic technology platform. The company develops non-invasive cancer diagnostic solutions which will help to detect, monitor, and assess early cancer treatment. Its research and development are focused on the role that metabolomics plays in early cancer detection. The company's objective is to commercialize its inventive technology. and strive to increase the predictive accuracy in early-stage cancer detection.

Biomark Diagnostics Headlines

No Headlines